3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Failure
1
Hepatitis C
1
Hepatitis B
1
Hepatic Insufficiency
1
HIV Infections
1
Carcinoma, Hepatocellular
1
Interventions
Gemcitabine
15
Cisplatin
12
Radiotherapy
11
Metformin
8
Fluorouracil
8
Capecitabine
8
Paclitaxel
7
Oxaliplatin
7
Exercise
7
Indocyanine Green
6
Docetaxel
6
Cyclophosphamide
6
Control Groups
6
Surveys and Questionnaires
5
Standard of Care
5
Nivolumab
5
Letrozole
5
Irinotecan
5
pembrolizumab
4
durvalumab
4
Zoledronic Acid
4
Vinorelbine
4
Saline Solution
4
Preoperative Exercise
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Ifosfamide
4
Gefitinib
4
Drug Therapy
4
Carboplatin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
OTHER_GOV
×
Raltegravir Potassium
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled